ANNX
Annexon
–
Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;
Marketcap: 877.53M; Volume: 399.69K; AvgVol 3m: 345.54K; Beta: –;
Cost estimate:
P/E: –; EPS: -0.22; EPS growth quarter/prev quarter: -29.40%;
EPS growth this year: -107.10%; EPS growth past 5 years: ;
EPS ttm: -0.24;
P/S: ; P/B: ; P/Cashflow: 8.95; P/FCF: ;
Sales: –; Sales growth quarter/prev quarter: ; Sales growth past 5 years: ;
Profitability:
Gross Margin: ; Profit Margin: ; Operating Margin: ;
ROA – return on assets: -64.30%; ROE – return on equity: 42.40%; LT Debt/Equity: ; Total Debt/Equity: ;
Dividend: –; Dividend Yield (%): –;
Insider Ownership: ; Insider Transactions:;
Institutional Ownership: ; Institutional Transactions: ;
Data update: 07/10/2020.